The DIU project, dubbed Predictive Health, is a collaboration with the DHA, three private-sector businesses and the DOD’s Joint Artificial Intelligence Center.
Using de-identified DOD medical imagery, project leaders will train the AI to identify cancers in patient scans. The AI will then be used with augmented reality microscopes to help medical professionals better identify cancer cells. The project aims to help support clinicians when making diagnoses, said Nathanael Higgins, support contractor managing the program.
“Medical professionals are already overworked,” Mr. Higgins said. “We’re essentially giving them an additional tool that will help them make confident decisions — and know that they made the right decision — so that we’re not facing as many false negatives or false positives. And ultimately we’re able to identify these types of disease states earlier, and that’ll help the long-term prognosis.”
The Predictive Health project is expected to finish within 24 months, after which it may be rolled out to practitioners for more testing, according to the report.
More articles on artificial intelligence:
AMA: IT experts must enlist medical ethicists, clinicians to strike potential biases in AI health tech
NYU Langone, Facebook set out to develop AI-powered 5-minute MRI scan
Healthcare provider and payer execs point to AI, robotics as next industry disruptors: report
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
